Pharmaniaga Bhd (XKLS:7081) Long-Term Debt: RM299 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7081 Pharmaniaga Bhd XKLS:7081
67 GF Score
Price RM1.16
GF Value RM1.12
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd Long-Term Debt?

Pharmaniaga Bhd XKLS:7081 -0.85% 67 Long-Term Debt is RM299 Mil as of Jun. 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 67/100 and a GF Value™ of RM1.12 (Fairly Valued). The stock has 6 warning signs investors should review.

Pharmaniaga Bhd's Long-Term Debt for the quarter that ended in Jun. 2026 was RM299 Mil.

Pharmaniaga Bhd's quarterly Long-Term Debt declined from Dec. 2025 (RM125 Mil) to Mar. 2026 (RM110 Mil) but then increased from Mar. 2026 (RM110 Mil) to Jun. 2026 (RM299 Mil).

Pharmaniaga Bhd's annual Long-Term Debt declined from Dec. 2023 (RM139 Mil) to Dec. 2024 (RM130 Mil) and declined from Dec. 2024 (RM130 Mil) to Dec. 2025 (RM125 Mil).

Pharmaniaga Bhd  (XKLS:7081) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pharmaniaga Bhd Long-Term Debt Related Terms

Pharmaniaga Bhd Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Pharmaniaga Bhd's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaniaga Bhd Long-Term Debt Chart

Pharmaniaga Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 284.99 91.67 138.62 129.57 125.40

Pharmaniaga Bhd Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.02 134.66 125.40 109.57 298.65
XKLS:7081
67GF Score
Pharmaniaga Bhd XKLS:7081
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of RM299 Mil mean?
Pharmaniaga Bhd (XKLS:7081) has a Long-Term Debt of RM299 Mil as of Jun. 2026.
Is Pharmaniaga Bhd's Long-Term Debt too high?
Pharmaniaga Bhd's current Long-Term Debt is RM299 Mil. Overall, Pharmaniaga Bhd has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Long-Term Debt compare to MCK and COR?
Pharmaniaga Bhd's Long-Term Debt of RM299 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Pharmaniaga Bhd's current Long-Term Debt is RM299 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Fairly Valued. The stock's GF Value™ is RM1.12, compared to a current price of RM1.16 — trading 3.6% above its estimated fair value. The current Long-Term Debt is RM299 Mil. Pharmaniaga Bhd's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Long-Term Debt is RM299 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.16 is trading 3.6% above its estimated GF Value™ of RM1.12. GuruFocus considers Pharmaniaga Bhd to be Fairly Valued.

Key valuation signals for XKLS:7081:

  • Long-Term Debt: RM299 Mil
  • GF Value™: RM1.12 vs. price of RM1.16 (3.6% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
67GF Score

Get the complete analysis for XKLS:7081

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.16
Price
RM1.12
GF Value